Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

Article type

Original Article


Article page

145-148


Authors Details

Ahmed Abdul Bari Hazari*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 1746

PDF Downloaded: 858


Safety and efficacy of Tiotropium bromide compared with placebo in COPD and Bronchial Asthma


Original Article

Author Details : Ahmed Abdul Bari Hazari*

Volume : 6, Issue : 4, Year : 2019

Article Page : 145-148

https://doi.org/10.18231/j.ijpp.2019.031



Suggest article by email

Get Permission

Abstract

Introduction: Tiotropium is well tolerated, with a safety profile comparable with that of placebo.
Objective: To know the safety and efficacy of Tiotropium bromide compared with placebo.
Material and Methods: The present clinical study was conducted in patients with stable as well as exacerbated COPD and Br. Asthma at Shadan Hospital, Telengana State from May 2015 to Feb 2016.
Results: In case of Br. Asthma patient (n-10), the FEV­1 improved to 0.18 L (26.16%) with respect to baseline 0.15 L (P value < 0>1/FVC ratio is improved by 65.10% (5.51%) with respect to the baseline 61.70% (P<0>th weeks of period. In case of COPD patients the FEV1 is improved by 0.17 L (23.64%) with respect to baseline 0.14 L (P value < 0>1/FVC value improved by 64.72% (7.11%) with respect to the baseline 60.42% (P value < 0>
Conclusion: In spirometric as well as clinically, placebo in COPD group patients (n-7) and Br. Asthma group patients (n-10) showed very less improvement, which is statistically not significant.

Keywords: Bronchial Asthama, COPD, Placebo, FEV­1, FEV1/FVC, FVC.


How to cite : Hazari A A B, Safety and efficacy of Tiotropium bromide compared with placebo in COPD and Bronchial Asthma. Indian J Pharm Pharmacol 2019;6(4):145-148

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.